AtriCure Investor Relations Material
Latest events
Q1 2025
AtriCure
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AtriCure Inc
Access all reports
AtriCure Inc develops and sells medical devices for the surgical treatment of atrial fibrillation and related conditions. The company offers ablation systems, surgical instruments, and cryoablation technologies used in both open-heart and minimally invasive procedures. The company is headquartered in Mason, Ohio, and its shares are listed on the NASDAQ.
Key slides for AtriCure Inc
Q1 2025
AtriCure Inc
Q1 2025
AtriCure Inc
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
ATRC
Country
🇺🇸 United States